首頁 > 市場調查報告書 > 製藥

呼吸器

市場調查報告書

商品編碼

1370351

氣喘治療市場：2023-2028 年全球產業趨勢、佔有率、規模、成長、機會與預測

Asthma Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

出版日期: 2023年10月15日 | 出版商:

IMARC | 英文 150 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

概要

2023-2028 年市場概況：

2022年全球氣喘治療市場規模達181億美元。展望未來，IMARC Group預計到2028年市場規模將達到206億美元，2023-2028年年複合成長率（CAGR）為2.34%。

氣喘治療藥物是指用於治療氣喘的各種藥物。氣喘通常由室內和室外致病因素引發，包括污染、過敏原和灰塵。這些治療藥物通常是支氣管擴張劑和抗發炎藥，包括皮質類固醇、長效BETA受體激動劑（LABA）、甲基黃嘌呤、免疫調節劑和白三烯調節劑。也使用許多可以吸入、注射或口服給藥的合併治療藥物。這些藥物可擴張進入肺部的通道，並使空氣流動以改善呼吸。它們還有助於清除肺部的黏液，從而輕鬆咳出。

氣喘治療市場趨勢：

氣喘和其他呼吸系統疾病的盛行率不斷上升，以及診斷技術的改進，是推動市場成長的關鍵因素之一。此外，大眾對有效氣喘治療方法的認知不斷提高也推動了市場的成長。例如，氣喘患者主要使用吸入性皮質類固醇進行治療，晚期或持續性氣喘患者則使用針對特定目標的藥物進行治療。對阻斷免疫球蛋白 E 和特定細胞因子的單株抗體 (mAb) 也有廣泛的需求。用於治療呼吸系統疾病的聯合療法的發展是另一個生長誘導因素。醫療保健支出的增加、醫學領域廣泛的研究和開發（R＆D）活動以及醫療保健基礎設施的改善是預計進一步推動市場的其他因素。

本報告回答的關鍵問題

2022 年全球氣喘治療市場規模有多大？
2023-2028年全球氣喘治療市場的預期成長率是多少？
推動全球氣喘治療市場的關鍵因素是什麼？
COVID-19 對全球氣喘治療市場有何影響？
根據藥物類別，全球氣喘治療市場的細分如何？
根據產品類型，全球氣喘治療市場的細分如何？
根據治療類型，全球氣喘治療市場的細分如何？
根據給藥途徑，全球氣喘治療市場的細分如何？
全球氣喘治療市場的關鍵地區有哪些？
誰是全球氣喘治療市場的主要參與者/公司？

北美洲
- 美國
  - 市場走向
  - 市場預測
- 加拿大
  - 市場走向
  - 市場預測
亞太地區
- 中國
  - 市場走向
  - 市場預測
- 日本
  - 市場走向
  - 市場預測
- 印度
  - 市場走向
  - 市場預測
- 韓國
  - 市場走向
  - 市場預測
- 澳洲
  - 市場走向
  - 市場預測
- 印尼
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
歐洲
- 德國
  - 市場走向
  - 市場預測
- 法國
  - 市場走向
  - 市場預測
- 英國
  - 市場走向
  - 市場預測
- 義大利
  - 市場走向
  - 市場預測
- 西班牙
  - 市場走向
  - 市場預測
- 俄羅斯
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
拉丁美洲
- 巴西
  - 市場走向
  - 市場預測
- 墨西哥
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
中東和非洲
- 市場走向
- 按國家/地區分類的市場細分
- 市場預測

第 11 章：SWOT 分析

概述
優勢
弱點
機會
威脅

第 12 章：價值鏈分析

第 13 章：波特五力分析

概述
買家的議價能力
供應商的議價能力
競爭程度
新進入者的威脅
替代品的威脅

第 14 章：價格分析

第15章：競爭格局

市場結構
關鍵參與者
關鍵參與者簡介
- AstraZeneca PLC
- Abbott Laboratories
- Amgen Inc.
- Biogen Inc.
- Boehringer Ingelheim International GmbH
- F. Hoffmann-La Roche Ltd.
- GlaxoSmithKline Plc
- Merck Sharp & Dohme Corp.
- Novartis International AG
- Sunovion Pharmaceuticals Inc.
- Teva Pharmaceutical Industries Ltd.

簡介目錄圖表

Product Code: SR112023A2338

Abstract

Market Overview 2023-2028:

The global asthma therapeutics market size reached US$ 18.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 20.6 Billion by 2028, exhibiting a growth rate (CAGR) of 2.34% during 2023-2028.

Asthma therapeutics refer to various pharmaceutical drugs that are used for the treatment of asthma. Asthma is usually triggered by indoor and outdoor causative agents, including pollution, allergens and dust. These therapeutics are usually bronchodilators and anti-inflammatory drugs, which include corticosteroids, long-acting beta-agonists (LABA), methylxanthine, immunomodulators and leukotriene modifiers. A number of combination therapy drugs are also used that can be inhaled, injected, or orally administered. These drugs expand the passageway into the lungs and enable the movement of air to improve breathing. They also aid in clearing mucus from the lungs that gets coughed out with ease.

Asthma Therapeutics Market Trends:

The increasing prevalence of asthma and other respiratory disorders, along with improvements in the diagnostic technologies, is one of the key factors driving the growth of the market. Furthermore, rising awareness among the masses regarding the availability of effective asthma therapeutics is also providing driving the market growth. For instance, asthmatic patients are primarily treated with inhaled corticosteroids and patients with advanced conditions or persistent asthma are treated with target-specific drugs. There is also an extensive demand for monoclonal antibodies (mAbs) that block immunoglobulin E and specific cytokines. The development of combination therapies for the treatment of respiratory diseases is acting as another growth-inducing factor. Increasing healthcare expenditures, extensive research, and development (R&D) activities in the field of medical sciences and improvements in the healthcare infrastructure are some of the other factors that are expected to drive the market further.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global asthma therapeutics market report, along with forecasts at the global, regional and country levels from 2023-2028. Our report has categorized the market based on drug class, product type, treatment type and route of administration.

Breakup by Drug Class:

Anti-Inflammatory Drugs

Bronchodilators

Combination Therapies

Breakup by Product Type:

Inhalers

Dry Powder Inhalers

Metered Dose Inhalers

Soft Mist Inhalers

Nebulizers

Pneumatic Nebulizers

Ultrasonic Nebulizers

Mesh Nebulizers

Breakup by Treatment Type:

Quick-Relief Medications

Long-Term Asthma Control Medications

Breakup by Route of Administration:

Inhalation

Oral

Parenteral

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being AstraZeneca PLC, Abbott Laboratories, Amgen Inc., Biogen Inc., Boehringer Ingelheim International GmbH, F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Merck Sharp & Dohme Corp., Novartis International AG, Sunovion Pharmaceuticals Inc. and Teva Pharmaceutical Industries Ltd.

Key Questions Answered in This Report

1. What was the size of the global asthma therapeutics market in 2022?
2. What is the expected growth rate of the global asthma therapeutics market during 2023-2028?
3. What are the key factors driving the global asthma therapeutics market?
4. What has been the impact of COVID-19 on the global asthma therapeutics market?
5. What is the breakup of the global asthma therapeutics market based on the drug class?
6. What is the breakup of the global asthma therapeutics market based on the product type?
7. What is the breakup of the global asthma therapeutics market based on the treatment type?
8. What is the breakup of the global asthma therapeutics market based on the route of administration?
9. What are the key regions in the global asthma therapeutics market?
10. Who are the key players/companies in the global asthma therapeutics market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Asthma Therapeutics Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Drug Class

6.1 Anti-Inflammatory Drugs
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Bronchodilators
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Combination Therapies
- 6.3.1 Market Trends
- 6.3.2 Market Forecast

7 Market Breakup by Product Type

7.1 Inhalers
- 7.1.1 Market Trends
- 7.1.2 Major Types
  - 7.1.2.1 Dry Powder Inhalers
  - 7.1.2.2 Metered Dose Inhalers
  - 7.1.2.3 Soft Mist Inhalers
- 7.1.3 Market Forecast
7.2 Nebulizers
- 7.2.1 Market Trends
- 7.2.2 Major Types
  - 7.2.2.1 Pneumatic Nebulizers
  - 7.2.2.2 Ultrasonic Nebulizers
  - 7.2.2.3 Mesh Nebulizers
- 7.2.3 Market Forecast

8 Market Breakup by Treatment Type

8.1 Quick-Relief Medications
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Long-Term Asthma Control Medications
- 8.2.1 Market Trends
- 8.2.2 Market Forecast

9 Market Breakup by Route of Administration

9.1 Inhalation
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Oral
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
9.3 Parenteral
- 9.3.1 Market Trends
- 9.3.2 Market Forecast

10 Market Breakup by Region

10.1 North America
- 10.1.1 United States
  - 10.1.1.1 Market Trends
  - 10.1.1.2 Market Forecast
- 10.1.2 Canada
  - 10.1.2.1 Market Trends
  - 10.1.2.2 Market Forecast
10.2 Asia Pacific
- 10.2.1 China
  - 10.2.1.1 Market Trends
  - 10.2.1.2 Market Forecast
- 10.2.2 Japan
  - 10.2.2.1 Market Trends
  - 10.2.2.2 Market Forecast
- 10.2.3 India
  - 10.2.3.1 Market Trends
  - 10.2.3.2 Market Forecast
- 10.2.4 South Korea
  - 10.2.4.1 Market Trends
  - 10.2.4.2 Market Forecast
- 10.2.5 Australia
  - 10.2.5.1 Market Trends
  - 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
  - 10.2.6.1 Market Trends
  - 10.2.6.2 Market Forecast
- 10.2.7 Others
  - 10.2.7.1 Market Trends
  - 10.2.7.2 Market Forecast
10.3 Europe
- 10.3.1 Germany
  - 10.3.1.1 Market Trends
  - 10.3.1.2 Market Forecast
- 10.3.2 France
  - 10.3.2.1 Market Trends
  - 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
  - 10.3.3.1 Market Trends
  - 10.3.3.2 Market Forecast
- 10.3.4 Italy
  - 10.3.4.1 Market Trends
  - 10.3.4.2 Market Forecast
- 10.3.5 Spain
  - 10.3.5.1 Market Trends
  - 10.3.5.2 Market Forecast
- 10.3.6 Russia
  - 10.3.6.1 Market Trends
  - 10.3.6.2 Market Forecast
- 10.3.7 Others
  - 10.3.7.1 Market Trends
  - 10.3.7.2 Market Forecast
10.4 Latin America
- 10.4.1 Brazil
  - 10.4.1.1 Market Trends
  - 10.4.1.2 Market Forecast
- 10.4.2 Mexico
  - 10.4.2.1 Market Trends
  - 10.4.2.2 Market Forecast
- 10.4.3 Others
  - 10.4.3.1 Market Trends
  - 10.4.3.2 Market Forecast
10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast

11 SWOT Analysis

11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
- 15.3.1 AstraZeneca PLC
  - 15.3.1.1 Company Overview
  - 15.3.1.2 Product Portfolio
  - 15.3.1.3 Financials
  - 15.3.1.4 SWOT Analysis
- 15.3.2 Abbott Laboratories
  - 15.3.2.1 Company Overview
  - 15.3.2.2 Product Portfolio
  - 15.3.2.3 Financials
  - 15.3.2.4 SWOT Analysis
- 15.3.3 Amgen Inc.
  - 15.3.3.1 Company Overview
  - 15.3.3.2 Product Portfolio
  - 15.3.3.3 Financials
  - 15.3.3.4 SWOT Analysis
- 15.3.4 Biogen Inc.
  - 15.3.4.1 Company Overview
  - 15.3.4.2 Product Portfolio
  - 15.3.4.3 Financials
  - 15.3.4.4 SWOT Analysis
- 15.3.5 Boehringer Ingelheim International GmbH
  - 15.3.5.1 Company Overview
  - 15.3.5.2 Product Portfolio
- 15.3.6 F. Hoffmann-La Roche Ltd.
  - 15.3.6.1 Company Overview
  - 15.3.6.2 Product Portfolio
  - 15.3.6.3 SWOT Analysis
- 15.3.7 GlaxoSmithKline Plc
  - 15.3.7.1 Company Overview
  - 15.3.7.2 Product Portfolio
  - 15.3.7.3 Financials
  - 15.3.7.4 SWOT Analysis
- 15.3.8 Merck Sharp & Dohme Corp.
  - 15.3.8.1 Company Overview
  - 15.3.8.2 Product Portfolio
  - 15.3.8.3 Financials
  - 15.3.8.4 SWOT Analysis
- 15.3.9 Novartis International AG
  - 15.3.9.1 Company Overview
  - 15.3.9.2 Product Portfolio
  - 15.3.9.3 Financials
  - 15.3.9.4 SWOT Analysis
- 15.3.10 Sunovion Pharmaceuticals Inc.
  - 15.3.10.1 Company Overview
  - 15.3.10.2 Product Portfolio
  - 15.3.10.3 SWOT Analysis
- 15.3.11 Teva Pharmaceutical Industries Ltd.
  - 15.3.11.1 Company Overview
  - 15.3.11.2 Product Portfolio
  - 15.3.11.3 Financials
  - 15.3.11.4 SWOT Analysis

簡介目錄圖表

List of Figures

Figure 1: Global: Asthma Therapeutics Market: Major Drivers and Challenges
Figure 2: Global: Asthma Therapeutics Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Asthma Therapeutics Market: Breakup by Drug Class (in %), 2022
Figure 4: Global: Asthma Therapeutics Market: Breakup by Product Type (in %), 2022
Figure 5: Global: Asthma Therapeutics Market: Breakup by Treatment Type (in %), 2022
Figure 6: Global: Asthma Therapeutics Market: Breakup by Route of Administration (in %), 2022
Figure 7: Global: Asthma Therapeutics Market: Breakup by Region (in %), 2022
Figure 8: Global: Asthma Therapeutics Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 9: Global: Asthma Therapeutics (Anti-Inflammatory Drugs) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Asthma Therapeutics (Anti-Inflammatory Drugs) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Asthma Therapeutics (Bronchodilators) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Asthma Therapeutics (Bronchodilators) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Asthma Therapeutics (Combination Therapies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Asthma Therapeutics (Combination Therapies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Asthma Therapeutics (Inhalers) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Asthma Therapeutics (Inhalers) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Asthma Therapeutics (Nebulizers) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Asthma Therapeutics (Nebulizers) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Asthma Therapeutics (Quick-Relief Medications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Asthma Therapeutics (Quick-Relief Medications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Asthma Therapeutics (Long-Term Asthma Control Medications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Asthma Therapeutics (Long-Term Asthma Control Medications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Asthma Therapeutics (Inhalation) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Asthma Therapeutics (Inhalation) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Asthma Therapeutics (Oral) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Asthma Therapeutics (Oral) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Asthma Therapeutics (Parenteral) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Asthma Therapeutics (Parenteral) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: North America: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: North America: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: United States: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: United States: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: Canada: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: Canada: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Asia Pacific: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Asia Pacific: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: China: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: China: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: Japan: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: Japan: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: India: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: India: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: South Korea: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: South Korea: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: Australia: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: Australia: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: Indonesia: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: Indonesia: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: Others: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: Others: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: Europe: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: Europe: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: Germany: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: Germany: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: France: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: France: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: United Kingdom: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: United Kingdom: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: Italy: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: Italy: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: Spain: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: Spain: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: Russia: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: Russia: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: Others: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: Others: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: Latin America: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: Latin America: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: Brazil: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: Brazil: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: Mexico: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: Mexico: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: Others: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: Others: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Middle East and Africa: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 76: Middle East and Africa: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Global: Asthma Therapeutics Industry: SWOT Analysis
Figure 78: Global: Asthma Therapeutics Industry: Value Chain Analysis
Figure 79: Global: Asthma Therapeutics Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Asthma Therapeutics Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Asthma Therapeutics Market Forecast: Breakup by Drug Class (in Million US$), 2023-2028
Table 3: Global: Asthma Therapeutics Market Forecast: Breakup by Product Type (in Million US$), 2023-2028
Table 4: Global: Asthma Therapeutics Market Forecast: Breakup by Treatment Type (in Million US$), 2023-2028
Table 5: Global: Asthma Therapeutics Market Forecast: Breakup by Route of Administration (in Million US$), 2023-2028
Table 6: Global: Asthma Therapeutics Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 7: Global: Asthma Therapeutics Market Structure
Table 8: Global: Asthma Therapeutics Market: Key Players

02-2729-4219

+886-2-2729-4219